Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Eur Respir J ; 48(3): 826-32, 2016 09.
Article in English | MEDLINE | ID: mdl-27492835

ABSTRACT

We sought to assess whether laparoscopic anti-reflux surgery (LARS) is associated with decreased rates of disease progression in patients with idiopathic pulmonary fibrosis (IPF).The study was a retrospective single-centre study of IPF patients with worsening symptoms and pulmonary function despite antacid treatment for abnormal acid gastro-oesophageal reflux. The period of exposure to LARS was September 1998 to December 2012. The primary end-point was a longitudinal change in forced vital capacity (FVC) % predicted in the pre- versus post-surgery periods.27 patients with progressive IPF underwent LARS. At time of surgery, the mean age was 65 years and mean FVC was 71.7% pred. Using a regression model, the estimated benefit of surgery in FVC % pred over 1 year was 5.7% (95% CI -0.9-12.2%, p=0.088) with estimated benefit in FVC of 0.22 L (95% CI -0.06-0.49 L, p=0.12). Mean DeMeester scores decreased from 42 to 4 (p<0.01). There were no deaths in the 90 days following surgery and 81.5% of participants were alive 2 years after surgery.Patients with IPF tolerated the LARS well. There were no statistically significant differences in rates of FVC decline pre- and post-LARS over 1 year; a possible trend toward stabilisation in observed FVC warrants prospective studies. The ongoing prospective randomised controlled trial will hopefully provide further insights regarding the safety and potential efficacy of LARS in IPF.


Subject(s)
Gastroesophageal Reflux/surgery , Idiopathic Pulmonary Fibrosis/surgery , Laparoscopy , Adult , Aged , Disease Progression , Female , Gastroesophageal Reflux/complications , Humans , Hydrogen-Ion Concentration , Idiopathic Pulmonary Fibrosis/diagnosis , Male , Middle Aged , Perioperative Period , Regression Analysis , Respiratory Function Tests , Retrospective Studies , Smoking , Tomography, X-Ray Computed , Treatment Outcome , Vital Capacity
2.
J Allergy Clin Immunol ; 89(4): 866-76, 1992 Apr.
Article in English | MEDLINE | ID: mdl-1560169

ABSTRACT

The outer portions (husk) of psyllium seeds are a concentrated source of natural fiber used in some bulk-fiber laxatives and cereals. They are known to elicit respiratory allergic reactions after inhalation or ingestion among sensitized individuals. Antigenic and allergenic characterization of three psyllium-seed fractions (husk, endosperm, and embryo) was conducted with crossed immunoelectrophoresis (CIE), crossed radioimmunoelectrophoresis, and sodium dodecyl sulfate-polyacrylamide gel electrophoresis to determine the source of psyllium allergenicity. Homologous CIE demonstrated psyllium endosperm and embryo extracts contained seven and four antigens, respectively. Husk extracts were too gelatinous to react by CIE. However, heterologous CIE profiles of endosperm or embryo extracts, reacted with antihusk antibodies, resulted in antigen-antibody precipitin peaks that matched the heavy staining precipitin lines of homologous reactions for endosperm and embryo, respectively. These results indicated that commercial-grade husk, endosperm, and embryo contained similar antigens. Extracts of all three seed components contained antigens that bound IgE antibodies in the sera of 11 psyllium RAST-positive individuals, as determined by crossed radioimmunoelectrophoresis. The few prominent husk protein/peptide bands resolved by sodium dodecyl sulfate-polyacrylamide gel electrophoresis were common in either embryo or endosperm. Immunoblots revealed common IgE reactive bands in all three seed fractions. Microscopic examination of the powdered commercial-grade psyllium (95% pure) revealed it contained endosperm and embryo particles. These immunologic, biochemical, and microscopic findings suggest that other contaminating seed components are primarily responsible for the allergenicity of commercial-grade psyllium-husk powder rather than the husk itself.


Subject(s)
Allergens/analysis , Antigens/analysis , Plantago/immunology , Plants, Medicinal , Psyllium/immunology , Animals , Electrophoresis, Polyacrylamide Gel , Humans , Immune Sera , Immunodiffusion , Immunoelectrophoresis, Two-Dimensional , Microchemistry , Peptides/analysis , Plant Proteins/analysis , Rabbits/immunology , Radioallergosorbent Test , Radioimmunoassay , Sodium Dodecyl Sulfate
3.
Cancer Lett ; 37(3): 251-6, 1987 Nov.
Article in English | MEDLINE | ID: mdl-3119190

ABSTRACT

The induction of differentiation of SENCAR murine granulocyte-macrophage precursor cells (GM-CFU) by the tumor-promoting phorbol diester 12-O--tetradecanoyl-phorbol-13-acetate (TPA) was inhibited by agents reported to inhibit specific aspects of arachidonic acid metabolism. These agents included phospholipase A2 inhibitors, and eicosatetraynoic acid (ETYA), a competitive inhibitor of arachidonic acid oxygenases. Whereas inhibitors reported specific for lipoxygenases were also active, no comparable effect was observed for inhibitors of the corresponding cyclooxygenase. These findings are therefore consistent with the hypothesis that induced differentiation of GM-CFU cells is regulated by products of arachidonic acid metabolism formed principally via lipoxygenase activity.


Subject(s)
Arachidonic Acids/physiology , Cell Differentiation/drug effects , Granulocytes/cytology , Hematopoietic Stem Cells/cytology , Ibuprofen/pharmacology , Indomethacin/pharmacology , Lipoxygenase Inhibitors , Macrophages/cytology , Tetradecanoylphorbol Acetate/pharmacology , 5,8,11,14-Eicosatetraynoic Acid/pharmacology , Animals , Arachidonic Acid , Ascorbic Acid/pharmacology , Butylated Hydroxyanisole/pharmacology , Colony-Forming Units Assay , Dexamethasone/pharmacology , Masoprocol/pharmacology , Mice
SELECTION OF CITATIONS
SEARCH DETAIL
...